A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men
Starting soon · Not applicable
Conditions studied: Prostate Carcinoma
In brief
This clinical trial tests how well a point of prostate cancer diagnosis (PPCD) virtual reality assistant (ViRA) intervention works in supporting Black men with newly diagnosed prostate cancer. Cancer is the second leading cause of death for African American/Black men, with prostate cancer leading in estimated new cancer cases and second in estimated new cancer deaths. Over 40,000 African American/Black men are diagnosed with prostate cancer annually, with 1 in 6 lifetime probability of developing prostate cancer compared to 1 in 8 probability in White men. The PPCD ViRA provides psycho-oncology support, social determinants of health navigation and emotional support for ethnically diverse African American/Black men newly diagnosed with prostate cancer using artificial intelligence and augmented reality. Using PPCD ViRA may close the prostate cancer care gap for African American/Black men across the cancer continuum and provide emotional, educational, and resource needs of this population when they are visiting a doctor about their prostate health or prostate cancer.
Key facts
- Study ID
- NCT07126548
- Run by
- Mayo Clinic
- People needed
- 200
- Starts
- 2027-06-01
- Expected to finish
- 2029-09-02
- Last updated by the study team
- 2026-04-20
Who can join
Age: any. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- African American/Black male
- Diagnosed with CaP within two months
- Be a patient at a participating clinic or affiliates with one of our community sites
- Consent to participating in the study
You may not qualify if…
- Do not speak or understand English
- Unable to read or write
Where it is running
- Mayo Clinic in Florida — Jacksonville, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.